Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZANDU REALTY vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ZANDU REALTY   ACTAVIS
EQUITY SHARE DATA
    ZANDU REALTY
Mar-17
ACTAVIS
Dec-18
ZANDU REALTY/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,67016,136-   
Low Rs1,03010,824-   
Sales per share (Unadj.) Rs63.33,958.1-  
Earnings per share (Unadj.) Rs63.9-1,274.9-  
Cash flow per share (Unadj.) Rs63.9417.1-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs2,438.116,325.5-  
Shares outstanding (eoy) m0.81332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x21.23.4 623.5%   
Avg P/E ratio x21.0-10.6 -198.9%  
P/CF ratio (eoy) x21.032.3 65.1%  
Price / Book Value ratio x0.60.8 66.8%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,0894,483,446 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m30-   
Avg. sales/employee Rs Th077,898.1-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,091.0-  
INCOME DATA
Net Sales Rs m511,316,478 0.0%  
Other income Rs m11725,175 0.5%   
Total revenues Rs m1681,341,653 0.0%   
Gross profit Rs m-3734,498 -0.1%  
Depreciation Rs m0562,766 0.0%   
Interest Rs m1475,968 0.0%   
Profit before tax Rs m65-579,060 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,684 0.0%   
Tax Rs m14-7,338 -0.2%   
Profit after tax Rs m52-424,038 -0.0%  
Gross profit margin %-72.62.6 -2,770.7%  
Effective tax rate %20.81.3 1,639.3%   
Net profit margin %101.0-32.2 -313.5%  
BALANCE SHEET DATA
Current assets Rs m270539,950 0.0%   
Current liabilities Rs m118477,658 0.0%   
Net working cap to sales %295.94.7 6,253.2%  
Current ratio x2.31.1 202.3%  
Inventory Days Days12,98320 66,298.7%  
Debtors Days Days066 0.0%  
Net fixed assets Rs m1,824149,018 1.2%   
Share capital Rs m810-   
"Free" reserves Rs m1,8940-   
Net worth Rs m1,9755,429,856 0.0%   
Long term debt Rs m01,912,049 0.0%   
Total assets Rs m2,0938,488,101 0.0%  
Interest coverage x5.6-6.6 -84.4%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x00.2 15.8%   
Return on assets %3.2-4.1 -76.9%  
Return on equity %2.6-7.8 -33.6%  
Return on capital %4.0-4.8 -83.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m59470,328 0.0%  
From Investments Rs m-160258,384 -0.1%  
From Financial Activity Rs m101-807,224 -0.0%  
Net Cashflow Rs m0-78,120 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.39 Rs / USD

Compare ZANDU REALTY With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare ZANDU REALTY With: AARTI PHARMALABS  TTK HEALTHCARE  ROOPA INDUSTRIES  ZENITH HEALTH  ZYDUS LIFESCIENCES  



Today's Market

Gift Nifty Up 20 Points | Gland Pharma Receives USFDA Approval | Maruti Suzuki Crosses Rs 8 Trillion Mark | Top Buzzing Stocks Today Gift Nifty Up 20 Points | Gland Pharma Receives USFDA Approval | Maruti Suzuki Crosses Rs 8 Trillion Mark | Top Buzzing Stocks Today(Pre-Open)

Indian share markets continued the momentum as the session progressed and ended on firm footing.